Investing.com -- Bank of America (BofA) has upgraded Honeywell (NASDAQ:HON) to Buy from Neutral and raised its price objective on the stock to $250 from $210, citing a return to stable or positive earnings revisions following a solid first-quarter beat. The company’s shares rose more than 2% in premarket trading Wednesday. Advertisement: High Yield Savings Offers Earn up to 4.35% APY** with $5k balance View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. The bank’s analysts note that Honeywell had underperformed its industrial peers over the past two years, weighed down by negative revisions and missed expectations. “Honeywell is one of the most discounted names in our coverage on a terminal growth basis,” analysts led by Andrew Obin said in a note. “As we believe earnings have now stabilized, we believe the company can start to close some of the valuation gap vs. peers,” they added. The upgrade follows a better-than-expected Q1 report, with adjusted earnings per share (EPS) of $2.51 and improved full-year guidance. BofA lifted its 2025 EPS estimate to $10.44 from $10.27, now modestly above the $10.43 consensus. The 2026 forecast also rose to $11.54. BofA’s new price target is based on applying a valuation multiple of 17x estimated 2026 EV/EBITDA, reflecting improved earnings visibility, while still remaining below the 18x multiple at which peers are trading on 2025 estimates. According to the analysts, Honeywell’s more defensive business mix underpins the bullish call. The company’s exposure to longer-cycle segments like Aerospace, Building Solutions, and Process Solutions is seen as a cushion in a potentially softer macro environment. “In a recession scenario, we think HON would need to lower guide by less than peers, given a more defensive business mix,” the analysts noted. The report also highlights improved internal forecasting and guidance clarity following BofA’s meeting with CEO Vimal Kapur and CFO Mike Stepniak. The bank believes the company’s collaborative approach to targets improves visibility and investor confidence. Despite tariff-related headwinds embedded in the outlook—estimated at a 2.4% sales drag in the second half—Honeywell’s 2025 guidance is seen as achievable. “We think earnings have largely stabilized for 2025,” the analysts wrote, adding that the spin of Advanced Materials expected in 2026 won’t materially impact this year. Related articles Honeywell rises as BofA upgrades stock to Buy on a return to positive revisions Charles River to initiate a review amid Elliott stake - Is a sale next? Gilead Sciences to invest $11 billion in U.S. R&D and manufacturing View Comments
Honeywell rises as BofA upgrades stock to Buy on a return to positive revisions
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...